Pharmaceutical companies and unexpected drug side-effects

Subtypes of Hepatitis B Antigen in Blood Donors and Post-transfusion Hepatitis: Clinical and Epidemiological Aspects.

British medical journal·2010

Hepatitis A booster vaccination: is there a need?

Lancet (London, England)·2003

[New and re-emergent epidemics in the changing surrounding world].

Lakartidningen·1999

Studies on a Hib-tetanus toxoid conjugate vaccine: effects of co-administered tetanus toxoid vaccine, of administration route and of combined administration with an inactivated polio vaccine.

Vaccine·1999

Report from Working Group 3 (the Czech Republic, Denmark, Finland, Norway, The Netherlands, Slovakia, Sweden and the UK).

Vaccine·1999

Why the Scandinavian countries have not implemented universal vaccination against hepatitis B.

Vaccine·1999

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Understanding non-medical prescribers' antimicrobial prescribing and stewardship competency: A scoping review.

Research in social & administrative pharmacy : RSAP·2026

False Friends in Fluorescence - Simple HPLC Evaluation of False Positive Fragment Hits in a DiFMUP Assay for Protein Tyrosine Phosphatase 1B.

Drug design, development and therapy·2026

Insurance Noncoverage of Interventional Pain Procedures: Paving the Road Toward the Second Prescription Opioid Crisis.

Journal of pain research·2026

Rebalancing innovation, affordability, and access for orphan drugs in the European Union.

The Lancet regional health. Europe·2026

Clinical and Economic Burden of Diseases with Accelerated Approval Therapies: Evidence of Unmet Patient Need.

Therapeutic innovation & regulatory science·2026

The Hidden Burden of Parkinson's Disease in Cambodia: A Call to Action.

Public health challenges·2026

Related Experiment Videos

Pharmaceutical companies and unexpected drug side-effects

Related Concept Videos

Subtypes of Hepatitis B Antigen in Blood Donors and Post-transfusion Hepatitis: Clinical and Epidemiological Aspects.

Hepatitis A booster vaccination: is there a need?

[New and re-emergent epidemics in the changing surrounding world].

Studies on a Hib-tetanus toxoid conjugate vaccine: effects of co-administered tetanus toxoid vaccine, of administration route and of combined administration with an inactivated polio vaccine.

Report from Working Group 3 (the Czech Republic, Denmark, Finland, Norway, The Netherlands, Slovakia, Sweden and the UK).

Why the Scandinavian countries have not implemented universal vaccination against hepatitis B.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Understanding non-medical prescribers' antimicrobial prescribing and stewardship competency: A scoping review.

False Friends in Fluorescence - Simple HPLC Evaluation of False Positive Fragment Hits in a DiFMUP Assay for Protein Tyrosine Phosphatase 1B.

Insurance Noncoverage of Interventional Pain Procedures: Paving the Road Toward the Second Prescription Opioid Crisis.

Rebalancing innovation, affordability, and access for orphan drugs in the European Union.

Clinical and Economic Burden of Diseases with Accelerated Approval Therapies: Evidence of Unmet Patient Need.

The Hidden Burden of Parkinson's Disease in Cambodia: A Call to Action.

Related Experiment Videos

Pharmaceutical companies and unexpected drug side-effects

Related Concept Videos

Related Articles